Dry powder vaccine nears Phase I
A dry powder measles vaccine formulation and inhalers that could be as affordable as needle treatments are due to enter Phase I in 2010, according to researchers at the ACS meeting.
Archives for August 17, 2009
Appointments at Icon, MPI Research and Laxai – People on the move
Outsourcing-Pharma presents its latest round up of movements in the pharma outsourcing sector, including appointments at Icon, MPI Research and Laxai.
AsahiKasei rolls out new Swelstar excipients
Asahikasei’s chemicals unit has launched three new grades of pre-gelatinized starch excipients that it claims have broad application in the control of drug release, stability and disintegration.
Covance delays Virginia toxicity plant by 2 years
US CRO Covance has delayed the construction of a proposed $145m (€102m) preclinical toxicology testing facility at a 47 acre site at the Prince William Technology Park in Virginia.
Amcor offers over $2bn for Alcan packaging businesses
Australian packaging giant Amcor has offered to buy the European and Asian arms of Alcan Food Packaging along with its pharmaceutical and tobacco businesses for $2025m (€1434m).
PCAS joint venture sets up US kilolab
PCAS is setting up a kilolab in California, US to target the small-scale synthesis market, which it believes will benefit its large-scale operations by establishing relationships earlier in development.